Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes
Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes
This trial is conducted globally. The aim of the trial is to examine the dose range, escalation and efficacy of oral semaglutide in subjects with type 2 diabetes.
Inclusion Criteria:
Exclusion Criteria:
Saint Stefan, 8511, Austria
Århus C, 8000, Denmark
Saint Ingbert-Oberwürzbach, 66386, Germany